JPRN-UMIN000037233已完成未知
Effectiveness and Safety of Vibegron in Patients with Overactive Bladder: A Retrospective Chart Review of Patient Outcomes - Effectiveness and Safety of Vibegron in Patients with Overactive Bladder: A Retrospective Chart Review of Patient Outcomes
ishino Clinic, Koseikai Medical Corp.0 个研究点目标入组 100 人开始时间: 2019年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
We have evaluated the effects of vibegron on OAB. A total of 100 patients who had been administered vibegron once a day for at least 4 weeks between November 2018 and June 2019 were analyzed. The primary endpoint for effectiveness was the change in OABSS between baseline and four weeks. Four weeks after treatment, total OABSS score was significantly improved. No new safety concerns were identified.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
4 期
Prospective clinical study of switch to vibegron for overactive bladder patients with inadequate effect of antimuscarinics and mirabegron treatmentJPRN-jRCT1071230070Imamura Ryoichi30
已完成
3 期
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)Overactive BladderNCT03492281Urovant Sciences GmbH1,530
已完成
3 期
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).Overactive BladderNCT03583372Urovant Sciences GmbH506
已完成
不适用
Efficacy and safety of vibegron for treating overactive bladder: a prospective real-world studyoveractive bladderJPRN-UMIN000035771Department of Urology, Sapporo Medical University School of Medicine212
招募中
Unknown
Study of additional vibegron in persistent overactive bladderoveractive bladderJPRN-jRCTs031230450Yoshida Masaki160